Overview of The Incidence of Hyperprolactinemia Side Effects in Schizophrenia Patients With Antipsychotic Therapy
Abstract
Keywords
Full Text:
PDFReferences
Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Dis Prim. 2015 Nov 12;1.
Zahnia S, Wulan Sumekar D. Kajian Epidemiologic Skizofrenia. Majority [Internet]. 2016;5(5):1606. Available from: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/904/812
WHO. WHO | Schizophrenia. Schizophrenia. 2015.
RISKESDAS. Hasil Utama Riset Kesehatan Dasar 2018. Kementrian Kesehat Republik Indones. 2018;
Nandinanti IN, Yaunin Y, Nurhajjah S. Efek Electro Convulsive Therapy (ECT) terhadap Daya Ingat Pasien Skizofrenia di RSJ Prof. HB. Saanin Padang. J Kesehat Andalas. 2015;4(3):8838.
Chue P, Agyapong V, Abba-Aji A. Antipsychotic Drugs. In: Side Effects of Drugs Annual. 2018. p. 99119.
Barnes TRE. Neuroscience Perspectives Antipsychotic Drugs and their Side- Effects Series editor : Peter Jenner. Bloom FE, Brown DA, Carlsson A, Costa E, Fuxe K, Gessa GL, editors. Elsevier Science;
Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol. 2017;16(8):121023.
Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C. Hyperprolactinmies induites par les antipsychotiques : physiopathologie, clinique et surveillance. Encephale [Internet]. 2014 Feb [cited 2020 May 18];40(1):8694. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0013700612000449
Carvalho MM de, Gis C. [Hyperprolactinemia in mentally ill patients]. Acta Med Port [Internet]. 2011 [cited 2020 May 18];24(6):100512. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22713195
Ignjatovi? Risti? D, Cohen D, Obradovi? A, Niki?-?uri?i? K, Drakovi? M, Hini? D. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder. Nord J Psychiatry [Internet]. 2018;72(2):1249. Available from: https://doi.org/10.1080/08039488.2017.1400097
Madhusoodanan S, Parida S, Jimenez C. Hyperprolactinemia associated with psychotropics - A review. Human Psychopharmacology. 2010.
Majumdar A, Mangal NS. Hyperprolactinemia. Journal of Human Reproductive Sciences. 2013.
Binart N. Prolactin [Internet]. The Pituitary: Fourth Edition. Elsevier Inc.; 2017. 129161 p. Available from: http://dx.doi.org/10.1016/B978-0-12-804169-7.00005-2
Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management. Drugs. 2004;64(20):2291314.
Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review. CNS Drugs. 2014;28(5):42153.
Sathish Kumar S V., Sinha VK. Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia. Indian J Psychiatry. 2015 Oct 1;57(4):38691.
OKeane V. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia. J Psychopharmacol. 2008 Mar;22(2 SUPPL.):705
DOI: https://doi.org/10.30596/bf.v5i2.3761
DOI (PDF): https://doi.org/10.30596/bf.v5i2.3761.g4185
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: jurnalpanduhusada@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.